Implementation and outcome assessment of an inpatient antimicrobial stewardship program

Hospital Pharmacy

Volumn 47, Issue 12, 2012, Pages 939-945

  Hagert, Brandie L ^a   Williams, Cristin ^a   Wiesner, Catherine M ^a   Rohrich, Melissa A ^a   Lo, Tze Shien ^b   Newman, William P ^c,d   Koo, Ji M ^b,d  

^a Department of Pharmacy   (United States)

^b Fargo VA HCS ^*  (United States)

^c Endocrinology Department   (United States)

^d UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

antimicrobial resistance; antimicrobial stewardship program; ASP; infectious disease

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

AGED; ANTIMICROBIAL STEWARDSHIP PROGRAM; ANTIMICROBIAL THERAPY; ARTICLE; DRUG COST; DRUG UTILIZATION; FEMALE; HEALTH CARE PLANNING; HEALTH PROGRAM; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TREATMENT DURATION;

EID: 84871340938     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj4712-939     Document Type: Article

References (11)

1. Owens RC, Rice L. Hospital-based strategies for combating resistance. Clin Infect Dis. 2006;42:S173-181.
2. MacDougall C, Polk R. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18(4): 638-656.
3. Bancroft EA. Antimicrobial resistance. J Am Med Assoc. 2007;298:1803-1804.
4. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis. 2004;38:1279-1286.
5. Aiello AE, Nicholas BK, Foxman B. Ethical conflicts in public health research and practice: antimicrobial resistance and the ethics of drug development. Am J Public Health. 2006; 96(11):1910-1914.
6. Roberts RR, Hota B, Ahmad I, Scott RD, Foster SD, Abbasi F, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009;49:1175-84.
7. Dellit TH, Owens RC, McGowan JE, et al. Infectious Disease Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177.
8. Butler M, Cooper M. Antibiotics in the clinical pipeline in 2011. J Antibiotics. 2011;1-13.
9. Ruttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004;38:348-356.
10. Gentry C, Greenfield RA, Slater LN, Wack M, Huycke MM. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm. 2000;57(3):268-274.
11. Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003;24(9):699-706.